AUSTIN, Texas--(BUSINESS WIRE)-- DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the launch of the canal-sparing ...
The US Food and Drug Administration (FDA) on Friday proposed to reclassify non-invasive bone growth stimulators under two product codes from class III to class II, allowing the devices to be marketed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results